// App-Quantinova.ai

: Influence of Age on the Efficacy and Safety of Spironolactone in Heart Failure with Preserved Ejection Fraction

Researchers

Presenter

  • Orly Vardeny

Principal Investigators

  • Muthiah Vaduganathan

  • Brian Claggett

  • Akshay S. Desai

  • Inder S. Anand

  • Sanjiv J. Shah

  • Eileen O'Meara

  • Eldrin F. Lewis

  • Jean Rouleau

  • Bertram Pitt

  • Marc A. Pfeffer

  • Scott D. Solomon

Medical Centers

  • Minneapolis VA Health Care System, Minneapolis, MN

  • Brigham and Women's Hospital, Brookline, MA

  • Northwestern University, Chicago, IL

  • Montreal Heart Institute, Universite Montreal, Montreal, QC, Canada

  • University of Michigan, Ann Arbor, MI

Locations

  • United States

  • Canada

Companies

  • N/A

Study Components

Therapeutic Area

  • Blood/haematological Diseases

  • Cardiovascular (CVS)

  • Endocrine/metabolic Diseases (ME)

Disease

  • Heart failure with preserved ejection fraction

  • Cardiac arrest

  • Congestive heart failure

  • Hyperkalemia

  • Gynecomastia

Biomarkers

  • Creatinine

Drug/Treatment

  • Spironolactone

Outcome

  • N/A

Study Design

  • Randomized

  • Placebo Control

  • Multinational

  • Multicenteric

  • Prospective

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved